RENSSELAER, N.Y., Jan. 18 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body’s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role [...]
RENSSELAER, New York, Dec. 3 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random Integration Transgenic (RITg) service, which reduces animal model generation costs and timeline. Many gene editing technologies are used to generate animal models for drug discovery, each with unique considerations but with [...]
RENSSELAER, N.Y., Jan. 2 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal model production and colony management services through a new location in San Diego. Taconic can now provide critical drug discovery research solutions locally to west coast customers. The new [...]
RENSSELAER, N.Y., Jul. 29 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the first commercially available diet-induced NASH (nonalcoholic steatohepatitis) rodent model. NASH is a dangerous subtype of nonalcoholic fatty liver disease (NAFLD) and has recently garnered increased attention in the biomedical community due [...]
RENSSELAER, N.Y., Apr. 19 (Korea Bizwire) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis [...]
HUDSON, N.Y., Apr. 25 (Korea Bizwire) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective April 17, 2017, in conjunction with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), began commercial distribution of a new Parkinson’s disease mouse Model 13940 (C57BL/6- Lrrk2tm4.1Arte). The development of Model [...]